139 related articles for article (PubMed ID: 12011222)
1. Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.
Otieno MW; Banura C; Katongole-Mbidde E; Johnson JL; Ghannoum M; Dowlati A; Renne R; Arts E; Whalen C; Lederman MM; Remick SC
J Natl Cancer Inst; 2002 May; 94(10):718-32. PubMed ID: 12011222
[TBL] [Abstract][Full Text] [Related]
2. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome.
Gail MH; Pluda JM; Rabkin CS; Biggar RJ; Goedert JJ; Horm JW; Sondik EJ; Yarchoan R; Broder S
J Natl Cancer Inst; 1991 May; 83(10):695-701. PubMed ID: 2023270
[TBL] [Abstract][Full Text] [Related]
3. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
4. Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma.
Raphael BG; Knowles DM
Semin Oncol; 1990 Jun; 17(3):361-6. PubMed ID: 2191439
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
6. The occurrence of opportunistic non-Hodgkin's lymphomas in the setting of infection with the human immunodeficiency virus.
Pluda JM; Yarchoan R; Broder S
Ann Oncol; 1991 Feb; 2 Suppl 2():191-200. PubMed ID: 1646622
[TBL] [Abstract][Full Text] [Related]
7. The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Marvin V; Bower M
Cancer Treat Rev; 2004 May; 30(3):249-53. PubMed ID: 15059648
[TBL] [Abstract][Full Text] [Related]
8. Malignant tumors and AIDS.
Nasti G; Vaccher E; Errante D; Tirelli U
Biomed Pharmacother; 1997; 51(6-7):243-51. PubMed ID: 9309244
[TBL] [Abstract][Full Text] [Related]
9. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
10. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
11. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
12. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
13. Malignancies in HIV-Infected and AIDS Patients.
Ji Y; Lu H
Adv Exp Med Biol; 2017; 1018():167-179. PubMed ID: 29052137
[TBL] [Abstract][Full Text] [Related]
14. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
Diamond C; Taylor TH; Im T; Anton-Culver H
Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
[TBL] [Abstract][Full Text] [Related]
15. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Sparano JA; Wiernik PH; Hu X; Sarta C; Schwartz EL; Soeiro R; Henry DH; Mason B; Ratech H; Dutcher JP
J Clin Oncol; 1996 Nov; 14(11):3026-35. PubMed ID: 8918501
[TBL] [Abstract][Full Text] [Related]
16. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
17. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
[TBL] [Abstract][Full Text] [Related]
18. Advances and future challenges in non-Hodgkin's lymphoma.
Klencke B; Kaplan L
Curr Opin Oncol; 1998 Sep; 10(5):422-7. PubMed ID: 9800112
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases.
Lester R; Li C; Phillips P; Shenkier TN; Gascoyne RD; Galbraith PF; Vickars LM; Leitch HA
Leuk Lymphoma; 2004 Sep; 45(9):1881-5. PubMed ID: 15223650
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Tsimberidou AM; Sarris AH; Medeiros LJ; Mesina O; Rodriguez MA; Hagemeister FB; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F
Leuk Lymphoma; 2001 May; 41(5-6):535-44. PubMed ID: 11378571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
